Pharmaceutical Value proposition
New ways to care
Laboratoires Pierre Fabre held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise.
This makes Pierre Fabre Group :
💊 A pharmaceutical group with a strong positioning : medical and natural
🥈 The second largest dermo-cosmetics laboratory in the world
🥈 The second largest private French pharmaceutical group
🥇 The market leader in France for products sold over the counter in pharmacies.
Our portfolio includes several medical franchises and international brands including ;
Pharmaceutical Care
Pierre Fabre Oncologie
Pierre Fabre Dermatologie
Naturactive
Eau Thermale Avène
Klorane
Ducray
René Furterer
A-Derma
Pierre Fabre Oral Care
Glytone (US)
Darrow (Brasil)
Established in the Occitanie region since its creation, we manufacture over 95% of our products in France. We keep innovating passionately with our teams in 2 innovation centers in Brasil and Japan as well as in 6 R&D centers in France.
Thanks to our 9,600 employees in 44 subsidiaries and our distribution activities in 120 countries, our group generated €2.7 billion in revenues in 2022, 69% of which is from international business.
Pierre Fabre Group has a unique company structure.
86% of the Pierre Fabre Group is held by the Pierre Fabre Foundation, a government-recognized public-interest foundation, while a smaller share is owned by its employees via an employee stock ownership plan.
In 2020, the independent organization ECOCERT Environment awarded Pierre Fabre's CSR policy at "excellence" level : - Excellence being the highest maturity level of the ECOCERT 26000 standard.
From Health to Beauty, Family Health, Dermo-Cosmetics, Pharmaceuticals, De la Santé à la Beauté, Dermo-Cosmétique, Médicaments, Santé Familiale, oncology, skincare, haircare, and personal careOriginal language
New Ways To Care
Laboratoires Pierre Fabre held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise. This makes Pierre Fabre Group : 💊 A pharmaceutical group with a strong positioning : medical and natural 🥈 The second largest dermo-cosmetics laboratory in the world 🥈 The second largest private French pharmaceutical group 🥇 The market leader in France for products sold over the counter in pharmacies. Our portfolio includes several medical franchises and international brands including ; Pharmaceutical Care Pierre Fabre Oncologie Pierre Fabre Dermatologie Naturactive Eau Thermale Avène Klorane Ducray René Furterer A-Derma Pierre Fabre Oral Care Glytone (US) Darrow (Brasil) Established in the Occitanie region since its creation, we manufacture over 95% of our products in France. We keep innovating passionately with our teams in 2 innovation centers in Brasil and Japan as well as in 6 R&D centers in France. Thanks to our 9,600 employees in 44 subsidiaries and our distribution activities in 120 countries, our group generated €2.7 billion in revenues in 2022, 69% of which is from international business. Pierre Fabre Group has a unique company structure. 86% of the Pierre Fabre Group is held by the Pierre Fabre Foundation, a government-recognized public-interest foundation, while a smaller share is owned by its employees via an employee stock ownership plan. In 2020, the independent organization ECOCERT Environment awarded Pierre Fabre's CSR policy at "excellence" level : - Excellence being the highest maturity level of the ECOCERT 26000 standard.
Pierre Fabre | A French pharmaceutical and dermocosmetics group
Pierre Fabre | A French pharmaceutical and dermocosmetics group
https://www.pierre-fabre.com/en
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
 | IMPACT Partners Venture Capital and Private Equity Principals | Other 13 Dec 2017 | | |
 | Histalim biotech, deeptech, Biotechnology Research | Not capitalistic Not partnership Event 14 Jun 2017 | | |
 | Salina Consultants fintech, consulting, International Trade and Development | Not capitalistic Partnership Not event 17 Oct 2021 | | |
 | Malaria Consortium deeptech, healthtech, Non-profit Organizations | Other 11 Apr 2019 | | |
 | Jon Rees Associates Biotechnology Research | Other 23 Feb 2016 | | |
 | TBS Education Higher Education, edtech | Other 3 Dec 2021 6 Jan 2023 | | |
 | Les Petits Chaperons Rouges edtech, Individual and Family Services | Other 16 Nov 2021 | | |
 | Crédit Agricole Midcap Advisors fintech, Investment Banking | Capitalistic Not partnership Not event 23 Nov 2021 | | |
 | 360Medlink Inc it services, deeptech, healthtech, Hospitals and Health Care | Not capitalistic Partnership Not event 12 Jan 2022 | | |
 | Groupe Handéo civictech, silvertech, Civic and Social Organizations | Other 11 Jan 2022 3 Oct 2024 | | |